We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Metabolic Abnormalities Predict Heart Disease

By HospiMedica staff writers
Posted on 25 Jul 2003
A study has found that a more accurate predictor of heart disease than cholesterol levels is metabolic syndrome, a cluster of metabolic abnormalities. More...
The finding was reported in the July 15, 2003, issue of Circulation.

Under new guidelines, patients are considered to have metabolic syndrome if they have three or more of the following five conditions: abdominal obesity, high levels of trigyclerides, low levels of high-density lipoprotein (HDL), high blood sugar levels, and high blood pressure.

Researchers used data from a coronary study of 6,447 men in Scotland. All had moderately elevated levels of low-density lipoprotein (LDL). Using the new guidelines, 26% of the men had the metabolic syndrome, with almost twice the risk of heart disease and more than three times the risk of developing diabetes, compared to men without abnormalities. The risk increased as the number of abnormalities rose. Men with four or five abnormalities had almost four times the risk of heart disease and 24.5 times the risk of diabetes. The diabetes finding was important, since there are currently fewer predictive measures to identify people at risk of developing the disease.

"This is the first prospective study to show that the new criteria predict excess risk for both coronary heart disease and diabetes,” said lead author Naveed Sattar, M.D., a consultant in clinical biochemistry at the Glasgow Royal Infirmary (Scotland). The researchers also looked at another variable, C-reactive protein (CRP), a marker of inflammation that has been linked to heart disease. They found that CRP levels were also higher in men with the metabolic syndrome than in those without it.




Related Links:
Glasgow Royal Infirmary

Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Radiofrequency Generator
GX1
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.